This study is currently not recruiting participants.

A Phase 2 Multicenter 36-Week Study to Assess the Safety and Effectiveness of Daily Oral Administration of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis and Maintenance of Healed Erosive Esophagitis and Relief of Heartburn

Not Recruiting
12 years - 17 years
All
Phase N/A

Brief description of study.

The purpose of this study is to test the safety of dexlansoprazole in patients with erosive esophagitis.

Detailed description of study

The purpose of this study is to test the safety of dexlansoprazole in patients with erosive esophagitis.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions:
  • Age: 12 years - 17 years
  • Gender: All
Updated on 20 Aug 2013. Study ID: 1305011505

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team